CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($) $ in Thousands	Total	Underwriters' Option	Follow-on Public Offering	Common Stock	Additional Paid-in Capital	Additional Paid-in Capital Underwriters' Option	Additional Paid-in Capital Follow-on Public Offering	Accumulated Other Comprehensive Loss	Accumulated Deficit	Series A	Series A-1	Series B Preferred Stock	Class A Common Stock	Class A Common Stock Common Stock	Class A Common Stock Common Stock Underwriters' Option	Class A Common Stock Common Stock Follow-on Public Offering	Class B Common Stock	Class B Common Stock Common Stock
Beginning balance (in shares) at Dec. 31, 2019										3,379,400	1,837,600
Beginning balance at Dec. 31, 2019										$ 7,789	$ 10,270
Ending balance (in shares) at Dec. 31, 2020										3,379,400	1,837,600
Ending balance at Dec. 31, 2020										$ 7,789	$ 10,270
Beginning balance (in shares) at Dec. 31, 2019												4,681,400
Beginning balance (in shares) at Dec. 31, 2019				94,592,700										0				0
Beginning balance at Dec. 31, 2019	$ (1,159)			$ 0	$ 3,644			$ 0	$ (28,803)			$ 24,000		$ 0				$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				457,341
Issuance of common stock upon exercise of stock options	252				252
Stock-based compensation expense	1,079				1,079
Cumulative translation adjustment	0
Unrealized loss on investments	0
Net loss	(7,012)								(7,012)
Ending balance (in shares) at Dec. 31, 2020												4,681,400
Ending balance (in shares) at Dec. 31, 2020				95,050,041										0				0
Ending balance at Dec. 31, 2020	(6,840)			$ 0	4,975			0	(35,815)			$ 24,000		$ 0				$ 0
Increase (Decrease) in Temporary Equity [Roll Forward]
Conversion of preferred stock (in shares)										(3,379,400)	(1,837,600)
Conversion of preferred stock										$ (7,789)	$ (10,270)
Ending balance (in shares) at Dec. 31, 2021										0	0
Ending balance at Dec. 31, 2021										$ 0	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)																		1,194,918
Issuance of common stock upon exercise of stock options	1,327				1,327
Conversion of stock (in shares)				29,695,200								(4,681,400)		17,121,795				(17,121,795)
Conversion of preferred stock	18,058				42,058							$ (24,000)
Issuance of Class A Common Stock (in shares)														10,000,000	719,266	4,000,000
Issuance of Class A Common Stock	126,622	$ 9,245	$ 77,903		126,622	$ 9,245	$ 77,903
Reclassification of Common Stock to Class B Common Stock in connection with the initial public offering (in shares)				(124,745,241)														124,745,241
Reclassification of Common Stock to Class B Common Stock in connection with the initial public offering	0				(1)													$ 1
Vesting of Common Stock (in shares)																		51,762
Stock-based compensation expense	2,742				2,742
Cumulative translation adjustment	(230)							(230)
Unrealized loss on investments	0
Net loss	$ (3,285)								(3,285)
Ending balance (in shares) at Dec. 31, 2021	0											0
Ending balance (in shares) at Dec. 31, 2021				0									31,842,000	31,841,061			108,870,000	108,870,126
Ending balance at Dec. 31, 2021	$ 225,542			$ 0	264,871			(230)	(39,100)			$ 0		$ 0				$ 1
Ending balance (in shares) at Dec. 31, 2022										0	0
Ending balance at Dec. 31, 2022										$ 0	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	681,860													681,860
Issuance of common stock upon exercise of stock options	$ 981				981
Conversion of stock (in shares)														11,078,315				(11,078,315)
Vesting of Common Stock (in shares)														77,182				51,759
Issuance of shares in connection with Employee Stock Purchase Plan (in shares)														64,756
Issuance of shares in connection with Employee Stock Purchase Plan	758				758
Stock-based compensation expense	7,447				7,447
Cumulative translation adjustment	(851)							(851)
Unrealized loss on investments	(125)							(125)
Net loss	$ (33,848)								(33,848)
Ending balance (in shares) at Dec. 31, 2022	0											0
Ending balance (in shares) at Dec. 31, 2022				0									43,743,000	43,743,174			97,844,000	97,843,570
Ending balance at Dec. 31, 2022	$ 199,904			$ 0	$ 274,057			$ (1,206)	$ (72,948)			$ 0		$ 0				$ 1